Citations

Clear

3942 citation(s) found for "To, Van".

Prospective Diagnosis of 2-Methylbutyryl-CoA Dehydrogenase Deficiency in the Hmong Population by Newborn Screening Using Tandem Mass Spectrometry
Matern, Dietrich , He, Miao , Berry, Susan A. , Rinaldo, Piero, Whitley, Chester B. , Madsen, P. P., Calcar, Sandra C. Van, Lussky, Richard C., Andresen, Brage Storstein , Wolff, Jon A., Vockley, Jerry

Mayo Clinic

Pediatrics | August 14, 2004 | Volume: 112 | Issue: 1 | Pages: 74-78

10.1542/peds.112.1.74 | PMID 12837870 Get It

Objective. 2-Methylbutyryl-CoA dehydrogenase deficiency, also known as short/branched-chain acyl-CoA dehydrogenase (SBCAD) deficiency, is a recently described autosomal recessive disorder of l-isoleucine metabolism. Only 4 affected individuals in 2 families have been described. One patient developed athetoid cerebral palsy, and another had severe motor developmental delay with muscle atrophy. A sibling of the first patient is asymptomatic after prenatal diagnosis and early treatment. Family investigations in the second family revealed that the patient’s mother was also affected but asymptomatic. Methods. We report 8 additional patients identified by prospective newborn screening using tandem mass spectrometry. Results. Molecular genetic analysis performed for 3 of these patients revealed that all are homozygous for an 1165A>G mutation that causes skipping of exon 10 of the SBCAD gene. Although there was no obvious consanguinity, all patients belong to the Hmong, an ancient ethnic group that originated in China and constitutes only 0.8% and 0.6% of the Minnesota and Wisconsin population, respectively. Dietary treatment was initiated in the neonatal period. Except for 1 patient who developed mild muscle hypotonia, all patients remain asymptomatic at ages ranging from 3 to 14 months of age. Conclusions. These cases suggest that SBCAD deficiency is another inborn error of metabolism detectable by newborn screening using tandem mass spectrometry. The continued efficacy of long-term dietary therapy instituted presymptomatically remains to be established.
Results of Treatment of Pituitary Disease in Multiple Endocrine Neoplasia, Type I
O’Brien, Timothy , O'Riordan, D, Gharib, Hossein, Scheithauer, Bernd W., Ebersold, Michael J., Heerden, Jon A. van

Mayo Clinic

Neurosurgery | July 30, 2004 | Volume: 39 | Issue: 2 | Pages: 273-279

10.1097/00006123-199608000-00008 | PMID 8832664 Get It

The TALE Homeodomain Protein Pbx2 Is Not Essential for Development and Long-Term Survival
Selleri, Licia , DiMartino, Jorge, Deursen, Jan van, Brendolan, Andrea , Sanyal, Mrinmoy , Boon, Elles M. J., Smith, Kevin S. , Rhee, Joon Whan, Pöpperl, Heike, Grosveld, Gerard C. , Cleary, Michael L. , Capellini, Terence D.

Mayo Clinic

Molecular and Cellular Biology | May 28, 2004 | Volume: 24 | Issue: 12 | Pages: 5324-5331

10.1128/mcb.24.12.5324-5331.2004 | PMID 15169896 Get It

Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development
Conover, Cheryl A. , Bale, Laurie K., Overgaard, Michael T. , Johnstone, Edward W., Laursen, Ulla H., Füchtbauer, Ernst‐Martin , Oxvig, Claus , Deursen, Jan van

Mayo Clinic

Development | February 18, 2004 | Volume: 131 | Issue: 5 | Pages: 1187-1194

10.1242/dev.00997 | PMID 14973274 Get It

Pregnancy-associated plasma protein A (PAPPA) is a metzincin superfamily metalloproteinase in the insulin-like growth factor (IGF) system. PAPPA increases IGF bioavailability and mitogenic effectiveness in vitro through regulated cleavage of IGF-binding protein 4 (IGFBP4). To determine its function in vivo, we generated PAPPA-null mice by gene targeting. Mice homozygous for targeted disruption of the PAPPA gene were viable but 60% the size of wild-type littermates at birth. The impact of the mutation was exerted during the early embryonic period prior to organogenesis, resulting in proportional dwarfism. PAPPA, IGF2 and IGFBP4 transcripts co-localized in wild-type embryos, and expression of IGF2 and IGFBP4 mRNA was not altered in PAPPA-deficient embryos. However,IGFBP4 proteolytic activity was completely lacking in fibroblasts derived from PAPPA-deficient embryos, and IGFBP4 effectively inhibited IGF-stimulated mitogenesis in these cells. These results provide the first direct evidence that PAPPA is an essential growth regulatory factor in vivo, and suggest a novel mechanism for regulated IGF bioavailability during early fetal development.
Adrenal Tumors and Pregnancy
Harrington, Jennifer L., Farley, David R. , Heerden, Jon A. van, Ramin, Kirk D.

Mayo Clinic

Journal of Urology | November 18, 2003 | Volume: 162 | Issue: 3 Part 1 | Pages: 959-960

10.1097/00005392-199909010-00104 Get It

Osteogenesis Imperfecta, Perioperative Bleeding, and Desmopressin
Keegan, Mark T. , Whatcott, Brett D., Harrison, Barry

Mayo Clinic

Anesthesiology | November 10, 2003 | Volume: 97 | Issue: 4 | Pages: 1011-1013

10.1097/00000542-200210000-00039 | PMID 12357173 Get It

Gushing syndrome doe to ectopic adrenocorticotropic hormone secretion
Aniszewski, Jaroslaw P., Thompson, Geoffrey B. , Grant, Clive S., Heerden, Jon A. van, Young, William F.

Mayo Clinic

World Journal of Surgery | October 27, 2003 | Volume: 25 | Issue: 7 | Pages: 934-940

10.1007/s00268-001-0032-5 | PMID 11572035 Get It

AbstractGushing syndrome (CS) caused by ectopic adrenocorticotropic hormone (ACTH) production (EA) poses major challenges diagnostically by mimicking the pituitary‐dependent form of CS and therapeutically by producing severe, life‐threatening hypercortisolemia. This retrospective follow‐up study describes the clinical characteristics and course of EA in a large referral center. Computer‐based cross‐index codes for EA, CS, and bilateral adrenalectomy were used to identify patients treated at the Mayo Clinic between 1956 and 1998. EA was confirmed in 106 patients. Gender distribution showed a slight female predominance (61:45). Bronchial carcinoid was the most frequent cause of EA (25%), followed by islet cell cancer (16%), small‐cell lung carcinoma (11%), medullary thyroid cancer (8%), disseminated neuroendocrine tumor of unknown primary source (7%), thymic carcinoid (5%), pheochromocytoma (3%), disseminated gastrointestinal carcinoid (1%), and other tumors (8%). No tumor was found in 16% of patients. Altogether, 28 patients were managed medically, and the others underwent curative tumor resection (13 patients) or bilateral adrenalectomy (65 patients). Surgically treated patients had longer survival, but this was most likely affected by treatment bias. The diagnoses of CS and ACTH‐secreting neoplasm were usually concurrent, although, there were remarkable cases in which the two conditions were diagnosed several years apart. Curative resection of the tumor producing EA was possible in a small proportion of patients (12%). When curative resection is not possible, patients who are reasonable surgical candidates are likely to benefit from adrenalectomy. Additional experience with bilateral laparoscopic adrenalectomy should increase the number of patients who benefit from adrenal‐directed surgery.
Surgical Management of Duodenal Leiomyomas
Rice, David C. , Bakaeen, Faisal G. , Farley, David R. , Unni, K. Krishnan, Heerden, Jon A. van

Mayo Clinic

World Journal of Surgery | October 27, 2003 | Volume: 25 | Issue: 5 | Pages: 562-566

10.1007/s002680020083 | PMID 11369980 Get It

Abstract.Duodenal leiomyomas are rare neoplasms and when present are usually asymptomatic. There are, however, isolated case reports of such leiomyomas giving rise to complications including gastrointestinal hemorrhage and obstruction. The purpose of this study was to review the surgical experience with duodenal leiomyomas at a large tertiary referral center. A retrospective review was performed of all patients with histologically proven duodenal leiomyomas encountered from 1975 to 1995. Twelve patients with surgically treated duodenal leiomyomas were identified. There were eight men and four women with a mean age of 57 years (range 20–73 years) at diagnosis. Anemia was the presenting sign in 10 patients (83%). The mean hemoglobin level at presentation was 10.8 ± 2.67 g/dl. Other presenting signs included melena (n= 5) and epigastric tenderness (n= 4). No patient had obstructive symptoms. Upper endoscopy visualized the lesion in 9 of 10 patients, but endoscopic biopsy provided an accurate histologic diagnosis in only two of six patients biopsied. All resected specimens underwent frozen section and permanent histopathologic analysis. Local excision was performed in eight patients, as benignancy was anticipated at surgical exploration and frozen section findings. Two patients underwent segmental duodenal resection with primary end‐to‐end anastomosis, and two patients underwent a Whipple procedure. There was no perioperative mortality. Morbidity was minimal. There was no tumor recurrence during a median follow‐up of 8.4 years. Gastrointestinal blood loss is the most common complication of duodenal leiomyomas requiring surgical intervention. Small symptomatic leiomyomas with benign features may be safely treated with local excision.
Cushing’s Syndrome Due to Medullary Thyroid Carcinoma: Diagnosis by Proopiomelanocortin Messenger Ribonucleic Acid in Situ Hybridization
Smallridge, Robert C., Bourne, Kira L, Pearson, Bruce W. , Heerden, J A van, Carpenter, Paul C., Bourne, Kira L. , Young, William F.

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | October 13, 2003 | Volume: 88 | Issue: 10 | Pages: 4565-4568

10.1210/jc.2002-021796 | PMID 14557423 Get It

Abstract Medullary thyroid carcinoma (MTC) rarely causes ectopic ACTH syndrome. We describe a 38-yr-old man with renal stones who had a 5-cm MTC removed in 1992. He was RET-protooncogene positive (codon 618). Serum calcitonin was 1597 pg/ml postoperatively. In 1996 he had rib fractures, bruising, weakness, and three to four stools per day. Laboratory studies revealed an elevated 24-h urine-free cortisol (780 μg/d), epinephrine (66 μg/d), and calcium (558 mg/d). Baseline serum cortisol was 23.9 μg/dl and decreased to 12.9 and 4.5 μg/dl after 2 mg and 8 mg dexamethasone suppression, respectively. Plasma ACTH was 170 pg/ml and decreased to 75 and 24 pg/ml after dexamethasone. Bone density t-score was −4.3 (trochanter). Computed tomography scans showed multiple cervical nodes and 2-cm right adrenal nodule. Magnetic resonance imaging (MRI) scan showed a prominent, homogeneous pituitary; the adrenal MRI scan was not typical for a pheochromocytoma. Serum CRH was less than 6.6 pg/ml. Bilateral adrenalectomy revealed two adjacent right adrenal pheochromocytomas and corrected the elevated urine cortisol (30 μg/d), epinephrine (0 μg/d), and calcium (281 mg/d) but not plasma ACTH (125 pg/ml). Neck dissection reduced calcitonin by 96% (5300 to 120 pg/ml) and ACTH by 91% (125 to 11 pg/ml). Carcinoembryonic antigen was reduced from 32.0 to 2.3 ng/ml. Immunohistochemical stain was negative for ACTH in the MTC-positive lymph nodes and the pheochromocytoma. Proopiomelanocortin mRNA by in situ hybridization was positive in the MTC but not in the pheochromocytoma. A repeat pituitary MRI scan was normal. The differential diagnosis of ACTH-dependent Cushing’s syndrome in this case included pituitary disease or ectopic ACTH, either from medullary thyroid carcinoma or pheochromocytoma. ACTH stains were unrevealing, but proopiomelanocortin mRNA in situ hybridization in MTC tissue and plasma ACTH response to neck dissection confirmed MTC as the source of ectopic ACTH.